Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

PHASE3

Total Enrollment

705 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-02-27

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

An open label study to investigate the safety and efficacy of tradipitant in participants affected by motion sickness during travel

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness

NCT04327661

Motion Sickness

COMPLETED PHASE3

Motion Sifnos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness

NCT03772340

Motion Sickness

COMPLETED PHASE2

Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness

NCT05903924

Motion Sickness

COMPLETED PHASE3

Motion Sickness Medications and Vestibular Time Constant

NCT03270839

Drug Reaction

COMPLETED PHASE4

Prevention and Treatment of Nausea Associated With Motion Sickness in Senior Subjects

NCT03988530

Motion Sickness

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is an open label study to investigate the efficacy and safety of tradipitant in motion sickness affected male and female participants during events historically known to cause motion sickness.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Motion Sickness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Tradipitant Dose A

"See Drug"

Group Type EXPERIMENTAL

Tradipitant

Intervention Type DRUG

Oral Capsule

Tradipitant Dose B

"See Drug"

Group Type EXPERIMENTAL

Tradipitant

Intervention Type DRUG

Oral Capsule

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Tradipitant

Oral Capsule

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* History of Motion Sickness
* Age 18-75

Exclusion Criteria

* Nausea-inducing disorder other than motion sickness
* BMI \> 40
* History of intolerance and/or hypersensitivity to Neurokinin-1 Receptor antagonists

Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No